23 maio 2017 ano - Pembrolizumab Approved
Descrição:
FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.
Adicionado na linha do tempo:
Data:
~ 8 years and 4 months ago